TRCT
HOWL icon

Tower Research Capital (TRC)’s Werewolf Therapeutics HOWL Stock Holding History

Tower Research Capital (TRC)’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.56K Buy
+9,897
New +$6.03K ﹤0.01% 4513
2025
Q4 		– Sell
-6,004
Closed -$11.8K – 5332
2025
Q3 		$11.8K Sell
6,004
-8,373
-58% -$11.5K ﹤0.01% 3841
2025
Q2 		$15.7K Buy
14,377
+5,235
+57% +$5.39K ﹤0.01% 3804
2025
Q1 		$8.89K Buy
9,142
+3,286
+56% +$4.3K ﹤0.01% 3844
2024
Q4 		$8.67K Buy
5,856
+600
+11% +$1.22K ﹤0.01% 3975
2024
Q3 		$11.1K Sell
5,256
-18,511
-78% -$42.1K ﹤0.01% 3691
2024
Q2 		$58K Buy
23,767
+13,230
+126% +$63.5K ﹤0.01% 2984
2024
Q1 		$68.3K Buy
+10,537
New +$61.4K ﹤0.01% 2071
2023
Q4 		– Sell
-2,350
Closed -$5.03K – 6029
2023
Q3 		$5.03K Sell
2,350
-477
-17% -$1.31K ﹤0.01% 4775
2023
Q2 		$8.62K Buy
2,827
+1,303
+85% +$3.67K ﹤0.01% 4402
2023
Q1 		$4K Sell
1,524
-5,622
-79% -$16.8K ﹤0.01% 5072
2022
Q4 		$15K Buy
7,146
+615
+9% +$1.61K ﹤0.01% 3417
2022
Q3 		$30K Buy
6,531
+4,188
+179% +$22.7K ﹤0.01% 3601
2022
Q2 		$10K Sell
2,343
-374
-14% -$1.71K ﹤0.01% 4451
2022
Q1 		$12K Buy
2,717
+2,065
+317% +$14.5K ﹤0.01% 4062
2021
Q4 		$8K Buy
652
+234
+56% +$3.53K ﹤0.01% 4787
2021
Q3 		$7K Buy
418
+366
+704% +$6.25K ﹤0.01% 4647
2021
Q2 		$1K Buy
+52
New +$712 ﹤0.01% 5209

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.25M AUM 26.51% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tower Research Capital (TRC)'s HOWL Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in Werewolf Therapeutics (HOWL) in Q2 2026: 9,897 shares worth $3.56K. The stake represents ﹤0.01% of the portfolio and ranks #4513 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in HOWL as recently as Q3 2025.

Tower Research Capital (TRC) first reported a position in HOWL in Q2 2021 and has held it in 18 quarters since. The position peaked at $68.3K in Q1 2024. 45 funds tracked by Wall St. Rank hold HOWL as of Q2 2026.

  • Tower Research Capital (TRC) held 9,897 shares of Werewolf Therapeutics worth $3.56K as of Q2 2026.
  • Werewolf Therapeutics was a new Tower Research Capital (TRC) position in Q2 2026.
  • Werewolf Therapeutics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4513 holding.
  • Tower Research Capital (TRC) first reported a position in Werewolf Therapeutics in Q2 2021 and has held it in 18 quarters since.
  • Tower Research Capital (TRC)'s Werewolf Therapeutics position peaked at $68.3K in Q1 2024.
  • 45 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.